Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460835 · ClinicalTrials.gov registry record · NA
A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02460835 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 77 participants.
The verdict
NCT02460835, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
This is a pilot single arm study with the primary endpoints of feasibility and preliminary estimates of safety and efficacy. This protocol builds on over 25 years of experience with high dose liver RT (Radiation Therapy), and in particular adaptive RT aimed at adjusting the global radiation dose based on a patient's measured sensitivity to treatment. This current protocol uses functional imaging and specialized radiation planning techniques to spare highly functional portions of the liver to preserve function. The investigators feel this will further improve the safety and efficacy of RT for all patients by customizing treatments to each. If this approach is promising, the investigators will proceed to a phase II randomized study of standard versus spatially and dosimetrically adapted RT.
Interventions
- RADIATION Adaptive Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-01-26 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460835
The ClinicalTrials.gov registry entry for NCT02460835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adaptive Radiation Therapy is the first listed.
NCT02460835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460835 about?
NCT02460835 is a clinical study titled "A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma". This is a pilot single arm study with the primary endpoints of feasibility and preliminary estimates of safety and efficacy. This protocol builds on over 25 years of experience with high dose liver RT (Radiation Therapy), and in particular adaptive RT aimed at adjusting the global radiation dose bas...
What is the current status of trial NCT02460835?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2016-01-26. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT02460835?
The interventions under investigation include: Adaptive Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT02460835?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.